Setup News Ticker
Searching for 'Vaccine'. (Return)

Yahoo BusinessJan 25, 2021
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings

Moderna: Lab study confirms its COVID-19 vaccine still protects against new variants (MarketWatch MarketPulse)
Merck Stops Developing Both Of Its COVID-19 Vaccine Candidates (NPR Topics: Business)

Chicago Tribune Business NewsJan 25, 2021
Merck giving up on two potential COVID-19 vaccines after poor test results
Merck is halting work on two potential COVID-19 vaccines following poor results in early-stage studies.The drugmaker said it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.

Merck abandons bid to develop Covid-19 vaccine ( - US)

CNBC BusinessJan 25, 2021
Moderna says it's working on Covid booster shot for variant in South Africa, says current vaccine provides some protection

CDC: Moderna's COVID-19 vaccine can cause allergic reaction in some people (MarketWatch MarketPulse)

Google Business NewsJan 25, 2021
Coronavirus updates: 2 in 5 Americans live where hospitals are at capacity; Japan scrambling for 'herd immunity' ahead of Olympics - USA TODAY
Coronavirus updates: 2 in 5 Americans live where hospitals are at capacity; Japan scrambling for 'herd immunity' ahead of Olympics  USA TODAYMAP: Where to get the COVID-19 vaccine in Pennsylvania  The Morning CallSussex County COVID-19 January 24  TAPinto.netLetters to the Editor - Dallas-area residents share concerns and complaints about getting the COVID-19  The Dallas Morning News

Google Market NewsJan 25, 2021
Budweiser joins Coke, Pepsi brands in sitting out Super Bowl - Associated Press
Budweiser joins Coke, Pepsi brands in sitting out Super Bowl  Associated PressBudweiser becomes latest Super Bowl commercial stalwart to sit out this year's broadcast  USA TODAYBudweiser will sit out Super Bowl, funneling marketing dollars to boost vaccine awareness  CNBCBudweiser Joins Coke, Pepsi in Sitting Out Super Bowl  NBC 7 San Diego

NYTimes BusinessJan 25, 2021
Moderna Says Vaccine Still Protects Against Virus Variants
The vaccine yields fewer antibodies against the variant discovered in South Africa, and so the company plans to test an alternate version.

MarketWatch MarketPulseJan 25, 2021
Merck to discontinue development of COVID-19 vaccines, focus on two investigational therapies
Merck said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The decision comes after a review of findings from Phase 1 studies of the vaccine candidates, named V590 and V591, in which immune responses were inferior to those seen following natural infection and in trials of other vaccine candidates. "Merck continues to advance clinical programs and to scale-up manufacturing for two investigational medicines, MK-7110 and MK-4482 (molnupiravir); molnupiravir is being developed in collaboration with Ridgeback Bio," the company said in a statement. The company is expecting to book a charge in the fourth quarter, but did not offer any further details. Merck is still planning to submit the results of the early-stage trial for publication in a peer-reviewed journal. Shares fell 1.2% premarket and are down 6% in the last 12 months, while the S&P 500 has gained 16.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

Google Business NewsJan 24, 2021
More than two-thirds of Americans approve of Biden's coronavirus response: poll | TheHill - The Hill
More than two-thirds of Americans approve of Biden's coronavirus response: poll | TheHill  The HillBiden is planning a busy week of executive action. Here's what you need to know  CNNCDC director: "I cannot tell you how much vaccine we have"  Yahoo NewsBiden's Two challenges: Covid and Congress | Meet The Press | NBC News  NBC NewsWhite House begins talks with lawmakers on COVID-19 relief  The Associated Press

Enterprise Application NewsDec 28, 2020
Businesses to boost collaboration spending in ‘21 as remote work continues
After scrambling in 2020 to keep business operations going amid a pandemic, companies are eyeing even higher spending in 2021 on collaboration tools to support remote workers. But with vaccines rolling out now and uncertainty about what a "hybrid workplace" might look like, those same companies are likely to spend cautiously due to uncertainty about the wider economic environment.

Even with vaccinations offering hope for something of a return to normal in the year ahead, remote work will remain a necessity for many organizations. More than half (54%) of respondents to a Pew survey published this month said they want to work from home "all or most of the time" when the coronavirus outbreak is over, while a third would do so "some of the time." Only 11% say they'd want to do this "rarely or never."

To read this article in full, please click here

StockBuy Market Futures How Week
Bidentravel American reinstate ban Covid
CovidCOVID-19 Vaccine positive Biden Merck
COVID-19vaccine Positive Merck toll President
VaccineCOVID-19 Covid Merck Moderna how
BusinessHow Capital Insider Oil pandemic
Earningsweek Futures Apple Ahead Tesla
ChinaBillion IPO Evergrande Biden Love
capitalbusiness Shares Evergrande EV surge
StocksBuy these Goldman Sachs warns

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News Analysis Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News - China, Economy & Trade - Financial Markets - Hedge Funds - Telecoms - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2021 CEOExpress Company LLC